Search for a report

GLOBAL OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

GLOBAL OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

The global OTC artificial tears market is anticipated to register a CAGR of 5.12% between 2021 and 2028, generating a revenue of $6445.9 million by 2028. While the base year considered for the market study is 2020, the forecasting period is from 2021 to 2028.

Artificial tears drug is used for the treatment of allergic conjunctivitis and dry eye syndrome. The growth of effective OTC artificial tears has become vital, owing to the surging incidence of eye surgeries and dry eye syndrome.

GLOBAL OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

Global OTC Artificial Tears Market by Formulation (Preservative Based, Non-preservative Based) Market by Product (Solution, Ointment, Gel, Spray Solution, Emulsion, Suspension) Market by Type of Container (Plastic Multi-dose Container, Plastic Single-dose Container, Spray) Market by Application (Dry Eye Syndrome, Allergies, Contact Lens Moisture Retention, Infections, Uv & Blue Light Protection, Other Applications) Market by Distribution Channel( Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) by Geography

Request free sample

The global OTC artificial tears market is anticipated to register a CAGR of 5.12% between 2021 and 2028, generating a revenue of $6445.9 million by 2028. While the base year considered for the market study is 2020, the forecasting period is from 2021 to 2028.

Artificial tears drug is used for the treatment of allergic conjunctivitis and dry eye syndrome. The growth of effective OTC artificial tears has become vital, owing to the surging incidence of eye surgeries and dry eye syndrome. otc-artificial-tears-market

To learn more about this report, request a free sample copy

Key factors propelling the global OTC artificial tears market growth:

  • Prevalence of allergic conjunctivitis and OTC artificial tears
    • Allergic conjunctivitis is considered one of the major causes of eye inflammation.
    • It is characterized by the swelling in the lining of the eye caused due to allergen.
  • Progressions in research and development within the optometry sector
  • Susceptibility of geriatric population to eye diseases
  • Demand for the OTC artificial tears for the treatment of patients

Major growth restraining factors:

  • Accessibility of substitute therapies
  • Risk of side effects related to the OTC artificial tears drug
    • The side effect caused due to OTC artificial tears such as redness, swelling of muscle surrounding the eye, itching, and temporary blurred vision is anticipated to limit the growth of the OTC artificial tears market.

The report scope of the global OTC artificial tears market includes segmentation analysis based on formulation, product, type of container, application, and distribution channel. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Dry Eye Syndrome
    • Dry eye syndrome is the dominating application.
    • Dry eye syndrome arises due to the lack of proper moisture required for nourishing and lubricating the eye to provide clear vision.
    • Redness of the eye, itching, and burning sensation are some of the common symptoms of dry eye.
  • UV & Blue Light Protection
    • UV & blue light protection is the fastest-growing application.
    • High exposure to UV and blue light damage the eye tissue and nerves, further developing eye sunburn, dry eye syndrome, or cataracts.
    • The use of artificial tears provides relief from the symptoms of dry eye syndrome.
  • Allergies
  • Contact Lens Moisture Retention
  • Infections
  • Other Applications

Geographically, the global OTC artificial tears market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2020.
    • An increase in the geriatric population propels the growth of the region’s market. For instance, According to Population Reference Bureau (PRB), the number of Americans aged 65 years and above is projected to increase tenfold from 52 million in 2018 to 95 million by 2060.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Thailand, Indonesia, Singapore, and Rest of Asia-Pacific
    • The Asia-Pacific is the leading regional market across the global OTC artificial tears market.
    • The rise in environmental pollution is one of the major factors responsible for ocular disease, leading to irritation and dry eye syndrome.
    • An increase in the geriatric population, the rise in the number of cataract and glaucoma surgeries, and advancements in research and development propel the growth of the market.
  • Rest of World: Latin America, the Middle East & Africa

Major market players in the global OTC artificial tears market:

  • Allergan PLC (Acquired by Abbvie)
  • Bausch Health Companies Inc
  • Johnson & Johnson
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd

Key strategies adopted by some of these companies:

In February 2021, Abbvie launched REFRESH DIGITAL lubricant Eye Drops in North Chicago in order to increase its product portfolio. This product was used for the treatment of dryness and irritation of the eye caused due to everyday screen use.

Key findings of the global OTC artificial tears market:

  • Plastic multi-dose container is the fastest-growing type of container.
  • Emerging economies provide ophthalmic pharmaceutical companies with lucrative growth opportunities.
  • The preservative based segment dominated the formulation category in 2020.

 

Frequently Asked Questions (FAQs):

  • What are the different formulations of OTC artificial tears?

A: OTC artificial tears are available in different formulations such as eye drops, solutions, gels, suspension, and ointments, for the management of dry eye syndrome.

  • How does the rising geriatric population advance the global OTC artificial tears market growth?

A: The rising geriatric population and changing lifestyles are anticipated to offer significant opportunities to the ophthalmic pharmaceutical industry, owing to the increased demand for medications for treatment.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • PREVALENCE OF ALLERGIC CONJUNCTIVITIS AND DRY EYE DISEASE
      • PROGRESSIONS IN RESEARCH AND DEVELOPMENT IN THE OPTOMETRY SECTOR
      • SUSCEPTIBILITY OF GERIATRIC POPULATION TO EYE DISEASES
      • DEMAND FOR THE OTC ARTIFICIAL TEARS FOR THE TREATMENT OF PATIENTS
    • KEY RESTRAINTS
      • ACCESSIBILITY OF SUBSTITUTE THERAPIES
      • RISK OF SIDE EFFECTS RELATED TO THE OTC ARTIFICIAL TEARS DRUG
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON OTC ARTIFICIAL TEARS MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY FORMULATION
    • PRESERVATIVE BASED
    • NON-PRESERVATIVE BASED
  3. MARKET BY PRODUCT
    • SOLUTION
    • OINTMENT
    • GEL
    • SPRAY SOLUTION
    • EMULSION
    • SUSPENSION
  4. MARKET BY TYPE OF CONTAINER
    • PLASTIC MULTI-DOSE CONTAINER
      • PRESERVATIVE-FREE SYSTEM
      • PRESERVED SYSTEMS
    • PLASTIC SINGLE-DOSE CONTAINER
    • SPRAY
      • PRESERVED SYSTEMS
      • PRESERVATIVE-FREE SYSTEM
  1. MARKET BY APPLICATION
    • DRY EYE SYNDROME
    • ALLERGIES
    • CONTACT LENS MOISTURE RETENTION
    • INFECTIONS
    • UV & BLUE LIGHT PROTECTION
    • OTHER APPLICATIONS
  2. MARKET BY DISTRIBUTION CHANNEL
    • DRUG STORES & RETAIL PHARMACIES
    • HOSPITAL PHARMACIES
    • ONLINE PHARMACIES
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • SINGAPORE
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • COMPANY PROFILES
      • AKORN INC
      • ALCON INC
      • ALLERGAN PLC (ACQUIRED BY ABBVIE)
      • BAUSCH HEALTH COMPANIES INC
      • JOHNSON & JOHNSON
      • NICOX SA
      • NOVARTIS AG
      • OASIS MEDICAL
      • OCUSOFT INC
      • SANTEN PHARMACEUTICAL CO LTD
      • SENTISS PHARMA PVT LTD
      • SIMILASAN CORPORATION
      • SUN PHARMACEUTICAL INDUSTRIES LTD
      • URSAPHARM ARZNEIMITTEL GMBH
      • VISUFARMA

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – OTC ARTIFICIAL TEARS

TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, BY GEOGRAPHIC REGION, 2019 AND 2050

TABLE 3: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 4: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 5: GLOBAL PRESERVATIVE BASED MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 6: GLOBAL PRESERVATIVE BASED MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL NON-PRESERVATIVE BASED MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 8: GLOBAL NON-PRESERVATIVE BASED MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 10: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 11: GLOBAL SOLUTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 12: GLOBAL SOLUTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 13: GLOBAL OINTMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 14: GLOBAL OINTMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 15: GLOBAL GEL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 16: GLOBAL GEL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL SPRAY SOLUTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 18: GLOBAL SPRAY SOLUTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 19: GLOBAL EMULSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 20: GLOBAL EMULSION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 21: GLOBAL SUSPENSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 22: GLOBAL SUSPENSION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 23: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 26: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 27: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 28: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 29: GLOBAL PRESERVATIVE-FREE SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 30: GLOBAL PRESERVATIVE-FREE SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 31: GLOBAL PRESERVED SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 32: GLOBAL PRESERVED SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 33: GLOBAL PLASTIC SINGLE-DOSE CONTAINER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 34: GLOBAL PLASTIC SINGLE-DOSE CONTAINER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 35: GLOBAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 36: GLOBAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 37: GLOBAL SPRAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 38: GLOBAL SPRAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 39: GLOBAL PRESERVED SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 40: GLOBAL PRESERVED SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 41: GLOBAL PRESERVATIVE-FREE SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 42: GLOBAL PRESERVATIVE-FREE SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 43: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 44: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 45: GLOBAL DRY EYE SYNDROME MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 46: GLOBAL DRY EYE SYNDROME MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 47: GLOBAL ALLERGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 48: GLOBAL ALLERGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 49: GLOBAL CONTACT LENS MOISTURE RETENTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 50: GLOBAL CONTACT LENS MOISTURE RETENTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 51: GLOBAL INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 52: GLOBAL INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 53: GLOBAL UV & BLUE LIGHT PROTECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 54: GLOBAL UV & BLUE LIGHT PROTECTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 55: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 56: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 57: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 58: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 59: GLOBAL DRUG STORES & RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 60: GLOBAL DRUG STORES & RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 61: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 62: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 63: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 64: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 65: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 66: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 67: NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 68: NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 69: LEADING PLAYERS OPERATING IN THE NORTH AMERICA OTC ARTIFICIAL TEARS MARKET

TABLE 70: EUROPE OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 71: EUROPE OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 72: LEADING PLAYERS OPERATING IN EUROPE OTC ARTIFICIAL TEARS MARKET

TABLE 73: ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 74: ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 75: LEADING PLAYERS OPERATING IN ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET

TABLE 76: REST OF WORLD OTC ARTIFICIAL TEARS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 77: REST OF WORLD OTC ARTIFICIAL TEARS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 78: LEADING PLAYERS OPERATING IN REST OF WORLD OTC ARTIFICIAL TEARS MARKET

TABLE 79: LIST OF MERGERS & ACQUISITIONS

TABLE 80: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 81: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 82: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, IN 2020

FIGURE 6: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRESERVATIVE BASED, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY NON-PRESERVATIVE BASED, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, IN 2020

FIGURE 9: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY OINTMENT, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY GEL, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY SPRAY SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY EMULSION, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY SUSPENSION, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, IN 2020

FIGURE 16: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PLASTIC MULTI-DOSE CONTAINER, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY PRESERVATIVE-FREE SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL PLASTIC MULTI-DOSE CONTAINER MARKET, BY PRESERVED SYSTEMS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PLASTIC SINGLE-DOSE CONTAINER, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL SPRAY MARKET, BY PRESERVED SYSTEMS, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL SPRAY MARKET, BY PRESERVATIVE-FREE SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, IN 2020

FIGURE 24: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DRY EYE SYNDROME, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY ALLERGIES, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTACT LENS MOISTURE RETENTION, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY INFECTIONS, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY UV & BLUE LIGHT PROTECTION, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, IN 2020

FIGURE 31: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL OTC ARTIFICIAL TEARS MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 34: NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 35: UNITED STATES OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: CANADA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: EUROPE OTC ARTIFICIAL TEARS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 38: GERMANY OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: FRANCE OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: UNITED KINGDOM OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: ITALY OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: RUSSIA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: BELGIUM OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: POLAND OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 47: CHINA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: JAPAN OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: INDIA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: AUSTRALIA & NEW ZEALAND OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: SOUTH KOREA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: INDONESIA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: THAILAND OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: SINGAPORE OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 55: REST OF ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: REST OF WORLD OTC ARTIFICIAL TEARS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 57: LATIN AMERICA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 58: MIDDLE EAST & AFRICA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY FORMULATION
    • PRESERVATIVE BASED
    • NON-PRESERVATIVE BASED
  2. MARKET BY PRODUCT
    • SOLUTION
    • OINTMENT
    • GEL
    • SPRAY SOLUTION
    • EMULSION
    • SUSPENSION
  3. MARKET BY TYPE OF CONTAINER
    • PLASTIC MULTI-DOSE CONTAINER
      • PRESERVATIVE-FREE SYSTEM
      • PRESERVED SYSTEMS
    • PLASTIC SINGLE-DOSE CONTAINER
    • SPRAY
      • PRESERVED SYSTEMS
      • PRESERVATIVE-FREE SYSTEM
  1. MARKET BY APPLICATION
    • DRY EYE SYNDROME
    • ALLERGIES
    • CONTACT LENS MOISTURE RETENTION
    • INFECTIONS
    • UV & BLUE LIGHT PROTECTION
    • OTHER APPLICATIONS
  2. MARKET BY DISTRIBUTION CHANNEL
    • DRUG STORES & RETAIL PHARMACIES
    • HOSPITAL PHARMACIES
    • ONLINE PHARMACIES
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • SINGAPORE
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now